A systematic review on machine learning and deep learning techniques in the effective diagnosis of Alzheimer's disease.

Alzheimer's disease (AD) is a brain-related disease in which the condition of the patient gets worse with time. AD is not a curable disease by any medication. It is impossible to halt the death of brain cells, but with the help of medication, the effects of AD can be delayed. As not all MCI patients will suffer from AD, it is required to accurately diagnose whether a mild cognitive impaired (MCI) patient will convert to AD (namely MCI converter MCI-C) or not (namely MCI non-converter MCI-NC), during early diagnosis. There are two modalities, positron emission tomography (PET) and magnetic resonance image (MRI), used by a physician for the diagnosis of Alzheimer's disease. Machine learning and deep learning perform exceptionally well in the field of computer vision where there is a requirement to extract information from high-dimensional data. Researchers use deep learning models in the field of medicine for diagnosis, prognosis, and even to predict the future health of the patient under medication. This study is a systematic review of publications using machine learning and deep learning methods for early classification of normal cognitive (NC) and Alzheimer's disease (AD).This study is an effort to provide the details of the two most commonly used modalities PET and MRI for the identification of AD, and to evaluate the performance of both modalities while working with different classifiers.

A novel artificial intelligence-based predictive analytics technique to detect skin cancer.

One of the leading causes of death among people around the world is skin cancer. It is critical to identify and classify skin cancer early to assist patients in taking the right course of action. Additionally, melanoma, one of the main skin cancer illnesses, is curable when detected and treated at an early stage. More than 75% of fatalities worldwide are related to skin cancer. A novel Artificial Golden Eagle-based Random Forest (AGEbRF) is created in this study to predict skin cancer cells at an early stage. Dermoscopic images are used in this instance as the dataset for the system's training. Additionally, the dermoscopic image information is processed using the established AGEbRF function to identify and segment the skin cancer-affected area. Additionally, this approach is simulated using a Python program, and the current research's parameters are assessed against those of earlier studies. The results demonstrate that, compared to other models, the new research model produces better accuracy for predicting skin cancer by segmentation.

An Efficient Trust-Aware Task Scheduling Algorithm in Cloud Computing Using Firefly Optimization.

Task scheduling in the cloud computing paradigm poses a challenge for researchers as the workloads that come onto cloud platforms are dynamic and heterogeneous. Therefore, scheduling these heterogeneous tasks to the appropriate virtual resources is a huge challenge. The inappropriate assignment of tasks to virtual resources leads to the degradation of the quality of services and thereby leads to a violation of the SLA metrics, ultimately leading to the degradation of trust in the cloud provider by the cloud user. Therefore, to preserve trust in the cloud provider and to improve the scheduling process in the cloud paradigm, we propose an efficient task scheduling algorithm that considers the priorities of tasks as well as virtual machines, thereby scheduling tasks accurately to appropriate VMs. This scheduling algorithm is modeled using firefly optimization. The workload for this approach is considered by using fabricated datasets with different distributions and the real-time worklogs of HPC2N and NASA were considered. This algorithm was implemented by using a Cloudsim simulation environment and, finally, our proposed approach is compared over the baseline approaches of ACO, PSO, and the GA. The simulation results revealed that our proposed approach has shown a significant impact over the baseline approaches by minimizing the makespan, availability, success rate, and turnaround efficiency.

Intelligent system based comparative analysis study of SARS-CoV-2 spike protein and antigenic proteins in different types of vaccines.

Background: Coronaviruses, members of the Coronavirinae subfamily in the Coronaviridae family, are enveloped and positive-stranded RNA viruses that infect animals and humans, causing intestinal and respiratory infections. Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This disease appeared, for the first time (December 2019), in China and has spread quickly worldwide causing a large number of deaths. Considering the global threat, the World Health Organization (WHO) has declared, in March 2020, COVID-19 as a pandemic. Many studies suggest the great effect of the existing vaccines to protect against symptomatic cases of death by the COVID-19 virus. This paper, proposes to compare the main antigenic proteins sequences of the existing vaccines with Spike (S) protein of the SARS-CoV-2 genome. Our choice of S protein is justified by the major role that plays it in the receptor recognition and membrane fusion process based on an intelligent system. Herein, we focus on finding a correlation between S protein and compulsory vaccines in the countries that have a less death number by COVID-19 virus. In this work, we have used a combination of coding methods, signal processing, and bioinformatic techniques with the goal to localize the similar patterns between the S gene of the SARS-Cov-2 genome and 14 investigated vaccines. Results: A total of 8 similar sequences which have a size more than 6 amino acids were identified. Further, these comparisons propose that these segments can be implicated in the immune response against COVID-19, which may explain the wide variation by country in the severity of this viral threat. Conclusions: Our in silico study suggests a possible protective effect of Poliovirus, HIB, Hepatitis B, PCV10, Measles, Mumps, and Rubella (MMR) vaccines against COVID-19.